CRAIG EAGLE - 13 Dec 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Medical Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Craig Eagle
Issuer symbol
GH
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 17:20:41 UTC
Previous filing
02 Oct 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +29,861 $0.000000 29,861 13 Dec 2023 COMMON STOCK 29,861 $28.37 Direct F1
transaction GH RESTRICTED STOCK UNITS Award $0 +19,907 $0.000000 19,907 13 Dec 2023 COMMON STOCK 19,907 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
F2 This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F3 Not applicable for Restricted Stock Units.